Ashwagandha and saffron: what the research does and doesn't show

No published trial has tested ashwagandha and saffron together. They're studied separately, in different trial designs — saffron's mood and cognition research is often run against a drug-comparator arm rather than a placebo-only design, which is a different kind of evidence than most of ashwagandha's own literature. Here's what's documented about each on its own.

What the evidence doesn't support

It doesn't support ashwagandha and saffron, together or separately, as a treatment for depression or a diagnosed mood disorder. It doesn't support the idea that combining them produces a larger effect than either alone — that pairing has never been studied. And it doesn't support drawing a conclusion from a trial's design alone: when a saffron trial uses an antidepressant or a dementia medication as its comparator arm, that tells you the two were tested side by side, not what the comparison found or which one "won."

What the trials found

Because no trial has combined ashwagandha and saffron, there's no dose, population or duration to report for the pairing itself. Ashwagandha's own research is covered separately at ashwagandha benefits: what the research does and doesn't show and ashwagandha and cortisol.

Saffron (Crocus sativus) has its own, differently structured literature. A 2025 review of saffron's clinical trials found the depression studies typically used around 30 mg/day of dried saffron stigma over about 6 weeks, and a separate add-on trial used 15 mg of crocin (a saffron constituent) twice daily alongside an SSRI. In cognitive-disorder research, trials used 30 mg/day of saffron over periods of 16 to 52 weeks in people with Alzheimer's disease. A detail worth noting: several of these trials were designed with a drug — an SSRI in the depression trials, a dementia medication in the cognitive trials — as the comparator arm, rather than a placebo-only design. That's a trial-design fact, not an outcome; it tells you what the study compared saffron to, not how that comparison came out.

Nothing in this review, or elsewhere, documents a specific interaction between saffron and ashwagandha when taken together.

Questions people ask

Can you take ashwagandha and saffron together?

No trial has tested it, and we haven't found a documented case of a specific problem from combining them. If you take an antidepressant, saffron's own trials have used an SSRI as a comparator or add-on arm, which is a reason to mention saffron to a doctor if you're on one — and the same applies to ashwagandha, which has its own separately documented interactions (see ashwagandha and medications: what to check).

Saffron vs ashwagandha — which is better for mood?

This page doesn't rank the two against each other. They're studied with different trial designs, for overlapping but not identical outcomes, and no trial has compared them head-to-head. A persistent low mood is a reason to talk to a doctor, not to choose between two supplements.

Ashwagandha and saffron together — is it safe?

Nothing in either ingredient's separate literature documents a specific problem with combining them, but that's an absence of a documented issue, not a tested-and-cleared combination. Each carries its own separate cautions worth checking on its own page.

When to talk to a doctor

Neither ashwagandha nor saffron is a treatment for depression or any other diagnosed mood disorder, and nothing above supports using either, alone or combined, as a substitute for medical care. If you take an antidepressant or any other prescription medication, bring both supplements to that conversation before starting either.

Related reading: ashwagandha benefits: what's established and what isn't, ashwagandha and medications: what to check, and ashwagandha and 5-HTP.